Which Approach to SupPORT When the Nodes Don't Get the Memo: Surprise pN2 Disease After Neoadjuvant Chemoimmunotherapy [0.03%]
当节点未接收备忘录时的替代支持方案：新辅助化疗免疫治疗后的意外pN2疾病
Marshall Harrell,Austin J Sim
Marshall Harrell
Proton Beam Radiation Therapy for All Children and Adolescents Globally: Is This a Realistic and Cost-Effective Goal? [0.03%]
全球所有儿童和青少年质子放疗：这是一项现实且具有成本效益的目标吗？
Jeannette D Parkes,Natia Esiashvili,Derek S Tsang et al.
Jeannette D Parkes et al.
Reduced-dose total skin electron beam radiotherapy in mycosis fungoides and Sézary syndrome: Systematic review and meta-analysis [0.03%]
低剂量全身电子束放射治疗曲霉病和塞扎里综合征的系统评价和meta分析
Samir Abai,Moritz Fabian Danzer,Chalid Assaf et al.
Samir Abai et al.
Introduction: Primary cutaneous T-cell lymphomas are a heterogeneous group of T-cell neoplastic entities associated with significant morbidity and high radio-sensitivity. Although research of reduced-dose radiation treatm...
Sarah Ashmeg,Ghada Aldosary,Yasir Yousif El-Amin et al.
Sarah Ashmeg et al.
War and armed conflict profoundly disrupt cancer care systems, with radiation therapy services among the most severely affected due to their static geography, reliance on stable infrastructure, specialized equipment, and a highly trained mu...
Impact of Tamoxifen Only after Lumpectomy for "Good Risk" Duct Carcinoma in Situ: Combined Analysis of the NRG Oncology/RTOG 9804 and ECOG-ACRIN E5194 Trials [0.03%]
乳腺导管原位癌改良根治术仅使用他莫昔芬的疗效：“低风险”患者的NRG肿瘤学/RTOG 9804和ECOG-ACRIN E5194试验的合并分析
Jean L Wright,Jennifer Moughan,Wendy A Woodward et al.
Jean L Wright et al.
Purpose: The NRG/RTOG 9804 trial randomized patients with "good risk" ductal carcinoma in situ (DCIS) to radiation (RT) or none following lumpectomy. The ECOG-ACRIN E5194 trial had a comparable cohort observed without RT....
Oncotype DX™ Recurrence Score (RS) in Very Small Tumors: Does RS Influence Clinical Outcome? [0.03%]
Oncotype DX™ 复发评分（RS）在非常小的肿瘤中的应用：RS 对临床结局有影响吗？
Atif J Khan,Olufela Koleoso,Charlie White et al.
Atif J Khan et al.
Purpose: Tumor size is an established and independent risk factor for locoregional recurrence (LRR) and distant metastasis (DM). More recently, the recurrence score (RS) calculated from a 21-gene expression assay (Oncotyp...
Carbon-Ion Radiation Therapy as Nonsurgical Treatment for Early-Stage Breast Cancer: 5-Year Results From the Phase 2 Part of the First Prospective Clinical Trial [0.03%]
碳离子放射治疗作为早期乳腺癌非手术疗法的五年结果：首次前瞻性临床试验二期报告
Noriyuki Okonogi,Kukimo Karasawa,Kazutoshi Murata et al.
Noriyuki Okonogi et al.
Purpose: To evaluate the long-term efficacy, safety, and cosmetic outcomes of carbon-ion radiation therapy (C-ion RT) as a nonsurgical treatment option for patients with early-stage breast cancer. ...
Memantine for Prevention of Cognitive Late Effects in Children and Adolescents Receiving Radiotherapy for Brain Tumors: A Randomized, Controlled, Pilot Trial [0.03%]
美金刚预防脑肿瘤放疗儿童和青少年认知后遗症的随机对照试点研究
Heather M Conklin,Raja B Khan,Jason M Ashford et al.
Heather M Conklin et al.
Background: Children receiving irradiation for brain tumors are at significant risk for cognitive deficits that notably impact quality of life. This is the first randomized, controlled, investigation of the feasibility, a...
Deciphering Radiation-Induced Lung Injury: From Therapeutic Challenges to Macrophage-Centered Molecular Mechanisms and Innovative Interventions [0.03%]
解码放射性肺损伤：从治疗挑战到巨噬细胞中心的分子机制和创新干预措施
Nan Yuan,Gang Zhao,Qi Zhang et al.
Nan Yuan et al.
Radiation-induced lung injury (RILI) is a life-threatening complication of thoracic radiotherapy for malignancies. It poses two challenges in clinical management: the progression from acute radiation pneumonitis to irreversible pulmonary fi...
Optimizing Transmission FLASH Radiotherapy for Large-Field Post-Mastectomy Breast Treatment [0.03%]
大范围乳房切除术后放射治疗的FLASH优化研究
Ahmal Jawad Zafar,Sunil William Dutta,Matthew Joseph Case et al.
Ahmal Jawad Zafar et al.
Purpose: We investigated the effect of scanning speed, beam configuration, and dose-rate modeling on the FLASH effect in post-mastectomy proton transmission beams (TB) planning and evaluated the potential of spot scanning...